Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease
- DOI
- 10.1186/s41687-022-00534-y
- Published
- 2022-12-23
- Container
- Journal of Patient-Reported Outcomes
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s41687-022-00534-y,
title = {Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease},
author = {Chad Gwaltney and Jonathan Stokes and Anthony Aiudi and Iyar Mazar and Sarah Ollis and Emily Love and Amel Karaa and Carrie R. Houts and R. J. Wirth and Alan L. Shields},
year = {2022},
journal = {Journal of Patient-Reported Outcomes},
doi = {10.1186/s41687-022-00534-y},
url = {https://doi.org/10.1186/s41687-022-00534-y}
}RIS
TY - JOUR TI - Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease AU - Chad Gwaltney AU - Jonathan Stokes AU - Anthony Aiudi AU - Iyar Mazar AU - Sarah Ollis AU - Emily Love AU - Amel Karaa AU - Carrie R. Houts AU - R. J. Wirth AU - Alan L. Shields PY - 2022 JO - Journal of Patient-Reported Outcomes DO - 10.1186/s41687-022-00534-y UR - https://doi.org/10.1186/s41687-022-00534-y ER -
APA
Gwaltney, C., Stokes, J., Aiudi, A., Mazar, I., Ollis, S., Love, E., Karaa, A., Houts, C. R., Wirth, R. J., & Shields, A. L. (2022). Psychometric performance of the Primary Mitochondrial Myopathy Symptom Assessment (PMMSA) in a randomized, double-blind, placebo-controlled crossover study in subjects with mitochondrial disease. Journal of Patient-Reported Outcomes. https://doi.org/10.1186/s41687-022-00534-y
Source records
- crossref · retrieved 2026-09-26T01:25:33.987Z